Applications of Quantum Chemistry in Pharmaceutical Process Development: Current State and Opportunities
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Application of computational methods to understanding and predicting properties of analogues for drug discovery has enjoyed a long history of success. However, the drug development space (post-candidate selection) is currently experiencing a rapid growth in this arena. Due to the revolution in computing hardware development and improved computational techniques, quantum chemical (QC) calculations have become an essential tool in this space, allowing results from complex calculations to inform chemical development efforts. As a result, numerous pharmaceutical companies are employing QC as part of their drug development workflow. Calculations cover the range of transition state calculations, reaction path determination, and potential energy surface scans, among others. The impact of this rapid growth is realized by providing an in-depth understanding of chemical processes and predictive insight into the outcome of potential process routes and conditions. This review surveys the state of the art in these drug development applications in the pharmaceutical industry. Statistics of computational methods, software, and other metrics for publications in the last 14 years (2005–2019) are presented. Predictive applications of quantum chemistry for influencing experiments in reaction optimization and catalyst design are described. Important gaps in hardware and software capabilities that need to be addressed in order for quantum chemistry to become a more practical and impactful tool in pharmaceutical drug development are discussed. Perspectives for the future direction of application of QC to pharmaceutical drug development are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hardware-efficient variational quantum eigensolver for small molecules and quantum magnets
Kandala, A., Mezzacapo, A., Temme, K., Takita, M., Brink, M., Chow, J. M., & Gambetta, J. M. (2017) · Nature · doi:10.1038/nature23879 · Cited by 2,982
Density functional theory with London dispersion corrections
Grimme, S. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.30 · Cited by 2,829
Fast and Accurate Modeling of Molecular Atomization Energies with Machine Learning
Rupp, M., Tkatchenko, A., Müller, K.-R., & von Lilienfeld, O. A. (2012) · Physical Review Letters · doi:10.1103/physrevlett.108.058301 · Cited by 2,312
Mardirossian, N., & Head-Gordon, M. (2017) · Molecular Physics · doi:10.1080/00268976.2017.1333644 · Cited by 2,307
ANI-1: an extensible neural network potential with DFT accuracy at force field computational cost
Smith, J. S., Isayev, O., & Roitberg, A. E. (2017) · Chemical Science · doi:10.1039/c6sc05720a · Cited by 1,921
Prediction Errors of Molecular Machine Learning Models Lower than Hybrid DFT Error
Faber, F. A., Hutchison, L., Huang, B., Gilmer, J., Schoenholz, S. S., Dahl, G. E., Vinyals, O., Kearnes, S., Riley, P. F., & von Lilienfeld, O. A. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00577 · Cited by 651
Christensen, A. S., Kubař, T., Cui, Q., & Elstner, M. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00584 · Cited by 446
Janet, J. P., & Kulik, H. J. (2017) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.7b08750 · Cited by 289
Machine learning for the structure–energy–property landscapes of molecular crystals
Musil, F., De, S., Yang, J., Campbell, J. E., Day, G. M., & Ceriotti, M. (2018) · Chemical Science · doi:10.1039/c7sc04665k · Cited by 216
Machine learning meets volcano plots: computational discovery of cross-coupling catalysts
Meyer, B., Sawatlon, B., Heinen, S., von Lilienfeld, O. A., & Corminboeuf, C. (2018) · Chemical Science · doi:10.1039/c8sc01949e · Cited by 209
Strategies and Software for Machine Learning Accelerated Discovery in Transition Metal Chemistry
Nandy, A., Duan, C., Janet, J. P., Gugler, S., & Kulik, H. J. (2018) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.8b04015 · Cited by 161
Cited by
Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR
Tropsha, A., Isayev, O., Varnek, A., Schneider, G., & Cherkasov, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00832-0 · Cited by 397
Perspective on the Current State-of-the-Art of Quantum Computing for Drug Discovery Applications
Blunt, N. S., Camps, J., Crawford, O., Izsák, R., Leontica, S., Mirani, A., Moylett, A. E., Scivier, S. A., Sünderhauf, C., Schopf, P., et al. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00574 · Cited by 192
A hybrid quantum computing pipeline for real world drug discovery
Li, W., Yin, Z., Li, X., Ma, D., Yi, S., Zhang, Z., Zou, C., Bu, K., Dai, M., Yue, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67897-8 · Cited by 67
“However, in the current landscape, the involvement of quantum computing in drug discovery is primarily restricted to conceptual validation, with minimal integration into real world drug design 19–24 .”
BackgroundQuantum computing for chemical and biomolecular product design
Andersson, M. P., Jones, M. N., Mikkelsen, K. V., You, F., & Mansouri, S. S. (2022) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2021.100754 · Cited by 66
“Computational design of both molecular scale catalysts [45,46] and heterogeneous”
BackgroundApplications and potential of in silico approaches for psychedelic chemistry
Karabulut, S., Kaur, H., & Gauld, J. W. (2023) · Molecules · doi:10.3390/molecules28165966 · Cited by 8
Metadata
- Authors
- Lam, Y.-H., Abramov, Y., Ananthula, R. S., Elward, J. M., Hilden, L. R., Nilsson Lill, S. O., Norrby, P.-O., Ramirez, A., Sherer, E. C., Mustakis, J., & Tanoury, G. J.
- Venue
- Organic Process Research & Development
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-23
- Volume
- 24
- Issue
- 8
- Pages
- 1496-1507
- ISSN
- 1083-6160 (ISSN-L)
- 1520-586X
- OpenAlex
- W3045352698
- Cited by
- 48
- References
- 11
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.